期刊文献+

胰岛素联合二甲双胍治疗2型糖尿病的临床观察

下载PDF
导出
摘要 目的评价胰岛素联合二甲双胍对2型糖尿病(T2DM)患者的降血糖作用,观察其有效性。方法对52例应用胰岛素治疗而血糖控制不佳的T2DM患者随机分成治疗组(加二甲双胍0.25~0.5g日三次)与对照组观察随访12周。结果与治疗前相比,治疗组空腹血糖(FPG),餐后血糖(2hPG),糖化血红蛋白(HbAIC)水平明显下降(P<0.001),甘油三脂(TG)胆固醇(TC)水平明显下降(P<0.05),高密度脂蛋白(HDL)水平明显上升(P<0.05),体质指数(BMI)明显降低(P<0.05)两组治疗后比较上述指标也分别具有显著性差异。结果应用胰岛素治疗而血糖控制不佳的T2DM患者联合应用二甲双胍可有效控制血糖,改善脂质代谢,减轻体重。
作者 张远莲
出处 《海南医学》 CAS 2005年第7期80-81,共2页 Hainan Medical Journal
  • 相关文献

参考文献2

二级参考文献9

  • 1[1]Brozinick JT, Roberts BR, Dohm GL. Defective signaling through Akt-2 and -3 but not Akt-1 in insulin -resistant human skeletal muscle: potential role in insulin resistance. Diabetes,2003, 52:935-941
  • 2[2]Wallace TM, Methews DR. The assessment of insulin resistance in man. Diabetic Med,2002,19:527-534
  • 3[3]Roith DL, Yehiel Z. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care,2001,24:588-597
  • 4[4]Clark SF, Molero JC, James DE. Release of insulin receptor substrate proteins from an intracellular complex coincides with the development of insulin resistance. J Biol Chem ,2000,275:3819-3826
  • 5[5]Krook A, Bjornhalm M, Galuska D, et al.Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 2000,49:284-292
  • 6[6]Haring HU. Pathogenisis of type 2 diabetes: are there common causes for insulin resistance and secretion failure. Exp Clin Endocrinol Diabetes,1999,107(suppl 2):s17-s23
  • 7[7]Ciaraldi TP, Kong ASP, Chu NV, et al. Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects. Diabetes,2002, 51:30-36
  • 8[8]Freid J, Everitt D, Boscia J. Rosiglitazone and hepatic failure. Ann Intern Med ,2000,132:164
  • 9贾伟平,中国糖尿病杂志,1995年,3卷,11页

共引文献148

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部